NEW YORK--(BUSINESS WIRE)--Assay Depot, Inc. today announced the launch of a preclinical research e-commerce platform developed in conjunction with AstraZeneca. Called the AstraZeneca Innovation Marketplace (“AIM”), the system allows researchers to access innovative preclinical services in just a few clicks. By simplifying and automating legal and administrative processes that previously took weeks or months, AIM helps shorten the research cycle and increases the pace of research.
“AIM simplifies the purchase of preclinical services from our external partners. It will make our researchers’ lives simpler and give them fingertip access to essential research resources,” said Dapo Ajayi, AstraZeneca’s Chief Procurement Officer. “We have made the strategic decision that the AIM platform will be the primary route for AstraZeneca to do business with our preclinical research suppliers in the future,” added Ajayi.
AIM has a unique research concierge (comprised of Assay Depot sourcing experts) that helps AstraZeneca select the most qualified suppliers and get price quotes and technical information. AIM is directly connected to AstraZeneca’s purchasing system so an order can be placed as soon as the right supplier is identified.
“Private research marketplaces like AIM represent the next step in the evolution of pharmaceutical R&D,” stated Kevin Lustig, Assay Depot’s CEO. “AIM delivers a simple and streamlined way to improve access to scientific materials, increasing the speed of drug research. It standardizes legal and billing paperwork and simplifies the purchase of research services from the long tail of 10,000 global preclinical suppliers.”
Transparency and access to innovation are cornerstones for success in any knowledge-based industry. Innovation marketplaces like AIM enable large pharmaceutical companies to maintain complete global transparency without sacrificing local control over most scientific sourcing decisions. The platform is not limited to large pharma; Assay Depot has also recently launched an external sourcing service for small pharma, biotechs and academic research institutes.
.webp)
Scientist.com
Scientist.com is the world’s largest and first platform built for the intricacies of scientific outsourcing.
We help pharmaceutical and biotechnology organizations discover, engage, manage, and scale relationships with the providers that support every stage of the pipeline—from discovery and preclinical research to clinical development, manufacturing, medical affairs, and commercialization. Through a centralized platform, organizations can access a global network of 6,000+ providers, streamline sourcing and procurement workflows, maintain compliance, manage supplier relationships, and leverage data-driven insights to make faster, more informed decisions.
Today, Scientist.com supports more than 130 life science organizations, including 24 of the world's top 30 pharmaceutical companies, helping teams reduce operational complexity, accelerate timelines, and bring innovations to patients faster. Our mission is to make it possible to cure all human disease by 2050.
.png)